ClinicalTrials.gov
public full text
Public Domain
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
The overall objective of the trial is to evaluate the effect of the triple therapy consisting of bempedoic acid (BA), ezetimibe (EZE), and high-intensity atorvastatin or rosuvastatin on changes in coronary plaque burden and plaque morphology in patients with coronary atherosclerosis without significant obstructive coronary artery disease and without prior history of an ischemic vascular event.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- High-intensity statin vs initial combination of statin and ezetimibe following a first coronary event: A nationwide population-based cohort study#26125
- Evidence review for statins: efficacy and adverse effects: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review C#2214
- Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques#1102399
- South Korean Pitavastatin Heart Failure Study#899438
- Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy#1044667
Record · ID 906140
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive